Solutions to Simplify DNA and RNA

Invitrogen has announced the introduction of two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. Both solutions provide basic and clinical researchers with an innovative workflow that greatly reduces the time, cost, and experimental variability associated with next-generation sequencing library preparation.

The RiboMinus™ kit and the E-Gel® SizeSelect™ 2% pre-cast agarose gels simplify the workflows and reduce the experimental time and cost of applications such as discovery and characterisation of the entire transcriptome, validation of whole genome association results, targeted re-sequencing, chromatin immunoprecipitation (ChIP), rare and somatic mutation detection, and epigenetic studies.

The solutions are compatible with next-generation high-throughput genome analysis platforms, including Life Technologies’ Applied Biosystems SOLiD™ System, Illumina’s Genome Analyser and Roche’s Genome Sequencer FLX System.

“Simplifying sequencing workflows enables researchers to generate more useful data per experiment and allow them to focus on the biology,” said Rob Bennett, Life Technologies’ Research and Development Leader for Advanced Sequencing Applications.

“Life Technologies is developing innovative solutions that will be compatible with all nextgeneration DNA sequencing platforms to accelerate research and meet the market demand for faster and cost-effective sequencing.”